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The impact of psychotic experiences in the
early stages of mental health problems in
young people
Kareen Heinze1,2* , Ashleigh Lin3, Barnaby Nelson4,5, Renate L. E. P. Reniers2,6, Rachel Upthegrove1,2,6,
Latoya Clarke7, Ayesha Roche8, Angelique Lowrie1 and Stephen J. Wood1,2,4,5
Abstract
Background: Anxiety and depressive symptoms and psychotic experiences constitute common features of
emerging mental disorders in young people. Psychotic experiences and the ultra-high risk (UHR) state for psychosis
appear to have a particular importance for clinical presentation, progression of symptomatology, quality of life and
functioning, but the impact of psychotic experiences in individuals seeking help at non-UHR services, compared to
UHR services, is under-researched.
Methods: Sixty-nine young people (Mage ± SD at baseline = 20.8 ± 2.6, range 16–26 years, 48 females) presenting to
mental health services were grouped according to UHR and non-UHR status. They were assessed at baseline for
anxiety and depressive symptoms, psychological distress, psychosocial functioning and quality of life. They were
followed up at three, six, and 12 months. Data were analysed using mixed linear modelling.
Results: UHR individuals reported higher levels of depressive symptoms and psychological distress, and lower levels
of role functioning and quality of life compared to non-UHR individuals. No differences were reported for anxiety
symptoms or social functioning. Decline in psychosocial functioning was not associated with clinical deterioration
or reduction of quality of life.
Conclusions: Psychotic experiences appear to be particularly associated with depressive symptoms and psychological
distress, impaired role functioning and quality of life in help-seeking young people in the medium-term. It is therefore
important to pay special attention to psychotic experiences in the early stages of mental health problems even if
psychotic symptoms are not the main motivation for help-seeking.
Keywords: Clinical staging, Youth mental health, Psychotic experiences, Ultra-high risk
Background
Mental illness is the major health problem experienced
by young people [1, 2]. While some individuals in this
age group have transient problems, many cases persist
into middle and older adulthood and can severely impair
psychosocial functioning. Adolescents and young adults
often present in a non-specific way, with symptoms of
depression and anxiety and psychotic experiences in the
early stage of many longer term mental disorders [3].
Predicting who will have recurrent or chronic problems
can be difficult, especially in the early stages of disorder.
One well researched example of early stage mental health
problems is the ultra-high risk (UHR) state for psychosis.
This refers to a presentation in which a young person expe-
riences positive psychotic symptoms in a sub-threshold or
transient form [4]. UHR individuals experience low psycho-
social functioning and may have comorbid psychiatric dis-
orders such as major depression [5, 6]. They frequently
have poor functional outcomes [7], and are at increased risk
of the onset of psychotic disorders [8] as well as
non-psychotic disorders in the long-term [9, 10].
Psychotic experiences are not only associated with psych-
otic disorders, but are also prevalent in non-psychotic
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psychiatric illnesses such as depressive and anxiety dis-
orders [11–13]. It has been hypothesised that psychotic
experiences are not only a specific risk factor for devel-
oping psychosis, but can be a general marker of risk for
a range of mental disorders [10, 14]. Indeed, in two
population studies they have been found to be a risk
factor for severe psychopathology more generally, not
just psychotic disorder, characterised by high comorbid-
ity and suicidal behaviour [15, 16].
This idea of an overlap between psychotic experiences
and depressive and anxiety symptoms suggests the utility
of a dimensional approach such as clinical staging. Using
a clinical staging model, mental disorders are considered
as dynamic syndromes that overlap and share aetiologies
and courses [17], developing from a state of undifferenti-
ated general symptoms and syndromes into more de-
fined clinical conditions [3]. There is also evidence for
bifactor [18] and unitary models including the “p-factor”
model [19] which propose a general distress or psycho-
pathology factor that underlies most common psychi-
atric disorders. Indeed, many risk factors, such as
genetic disposition, trauma, and stressful life events, are
shared between psychiatric illnesses [20].
The criterion of 30% decline in functioning or chronic
low functioning has been added to UHR criteria in an
attempt to increase the specificity of prediction of psych-
osis [21]. However, the European Prediction of Psychosis
study (EPOS) identified a substantial loss of sensitivity in
transitions when this drop in functioning was incorpo-
rated [22]. Except for the purpose of an enrichment
strategy that theoretically predicts transition, the inclu-
sion of this drop in functioning may be too restrictive
when considering individuals’ overall psychopathology
and too much focus on this functioning criterion risks
missing cases who will also transition to psychosis [23].
The aims of the current study were two-fold. Firstly,
we aimed to ascertain the role of positive psychotic ex-
periences in individuals who were seeking help for com-
mon, non-psychotic mental health problems. It was
hypothesised that those at UHR would cross-sectionally
and longitudinally experience greater impairment in
terms of higher psychopathology, poorer functioning
and lower levels of self-reported quality of life compared
to those identified as non-UHR.
Secondly, we investigated the role of functioning [21]
added to the UHR criteria with regards to its utility in
predicting clinical outcome and quality of life. We
hypothesised that those with psychotic experiences but
no functional decline and/or chronic low functioning
would not significantly differ from those at UHR for
psychosis (i.e. those with psychotic experiences and
functional decline and/or chronic low functioning) on
measures of psychotic and non-psychotic outcomes and
quality of life in the medium term.
Methods
Participants & procedure
Seventy-three participants who were experiencing mental
health problems took part in the baseline assessment of
this study. They were recruited from the South
Birmingham area of the United Kingdom via two clinical
services (Youthspace & Birmingham Healthy Minds).
Study inclusion criteria were being aged between 16 and
26 years and recent help-seeking (within 6 months of clin-
ical contact) for mental health problems. Youthspace was
a youth-focused secondary mental health service that pro-
vided support for young people (aged 16–25 years) with a
variety of diagnoses and had no specific exclusion criteria,
except for diverting individuals at UHR or with a first
episode of psychosis to Early Intervention services in the
South Birmingham area. Youthspace offered a variety of
treatments and case management provided by a
multi-disciplinary team. Birmingham Healthy Minds is a
primary care psychological therapies service offering brief
psychological therapy for individuals aged 16 and above
who present with depressive and anxiety symptoms. Their
exclusion criteria are bipolar disorder, psychosis, suicid-
ality or need of long-term care. Both services operated
primarily though general practitioner referral at the
time of study recruitment. Exclusion criteria for the
study were a lack of sufficient English and cognitive
ability to provide informed consent and adequately
complete assessments. The study was approved by the
West Midlands - Edgbaston Research Ethics Committee
(reference number: 12/WM/0135) and participants pro-
vided written informed consent.
Participants were either approached by their clinician
during a clinical session or after a session by a member
of the research team. Participants received some brief
verbal information about the study as well as an infor-
mation sheet and could either immediately arrange an
appointment for the baseline assessment if approached
by a member of the research team or sign a consent to
be contacted form if approached by a service staff mem-
ber. If the latter was the case, a member of the research
team would contact the participant by telephone or via
letter. A small number of participants were also re-
cruited via advertisements at Youthspace and Birming-
ham Healthy Minds. Those participants were screened
for meeting the inclusion criteria when getting in touch
with the research team. Individuals who were scheduled
for a baseline assessment, received a detailed participant
information sheet before they gave informed written
consent. Interview and questionnaire assessments were
administered by trained members of the research team
(KH, AL, LC, AR, AL, KC, HB, CS, EW, CB). Most as-
sessments were conducted in facilities of the University
of Birmingham. In rare cases home visits were con-
ducted or follow-up interviews were administered via
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telephone, if it was not possible for the participant to
come in.
80.8% (n = 59) of these individuals provided data for
the 3 month follow-up assessment, 75.3% (n = 55) for
the 6 month and 53.4% (n = 39) for the 12 month
follow-up assessment. 46.6% (n = 34) of individuals
provided data for all three follow-up assessments, 26%
(n = 19) for two follow-up assessments, 16.4% (n = 12)
for one follow-up assessment and 11% (n = 8) for none
of the follow-up assessments.
Interventions
Clinical care for participants included psychotropic medi-
cation and/or psychological therapies/counselling: of those
participants who were assessed at baseline, 50.7% (n = 37)
were taking antidepressant medication and an additional
5.5% (n = 4) were prescribed antipsychotic and/or mood
stabilising medication. Additionally, 52.1% (n = 38) of par-
ticipants were receiving counselling or some sort of ther-
apy (e.g. cognitive-behavioural or -analytic therapy) and
32.9% (n = 24) had been assessed or referred for therapy.
Measures
Participants completed an interview and self-report assess-
ment on the following measures at all four time points:
Comprehensive Assessment of At-Risk Mental States (CAARMS)
The CAARMS [4] is a semi-structured interview
designed to determine the at-risk mental state for
psychosis. The four subscales unusual thought content
(e.g. delusional mood, overvalued ideas), non-bizarre
ideas (e.g. suspiciousness, grandiosity), perceptual abnor-
malities (e.g. distortions, illusions, hallucinations), and
disorganised speech (e.g. difficulties with speech and
communication) quantify severity (0 = absent/never-6 =
psychotic and severe) and frequency (0 = absent/never-6
= continuous) of psychotic experiences. A combination
of intensity and frequency ratings allows for the deter-
mination of whether individuals meet criteria for being
at UHR for psychosis and for determining onset of first
episode psychosis (FEP). A score of at least three for
both intensity and frequency on at least one subscale
(with exception of at least four for intensity for disorga-
nised speech) indicates UHR status, if coupled with a de-
cline in functioning or chronic low functioning. The
CAARMS indicates UHR status if symptoms were
present over the last 12 months. An overall inter-rater
reliability of 0.85 has been reported and CAARMS
criteria displayed good concurrent (e.g. with the Brief
Psychotic Rating Scale) and predictive validity (e.g. higher
risk of transition to psychosis in individuals with an at-risk
mental state) [4].
Criteria for FEP are met if participants score a 6 on in-
tensity and at least a 4 for frequency on non-bizarre
ideas, unusual thought content or disorganised speech
or a 5–6 on intensity and a 4–6 on frequency for per-
ceptual abnormalities.
Social and Occupational Functioning Assessment Scale (SOFAS)
The SOFAS has been derived from the Global Assessment
Scale [24] which is a modestly reliable and valid measure
of psychiatric disturbance [25], and provides a rating of
overall psychological functioning on a scale from 0 to 100
[26]. The SOFAS is usually used to rate an individual’s
current functioning, however highest and lowest function-
ing ratings for the past 12 months were employed to de-
termine a drop in functioning. The researcher rated the
score on the SOFAS based on information provided in the
interview for the Global Functioning: Social and Role
Scales. The SOFAS has been included in the Diagnostic
and Statistical Manual for Psychiatric Disorders IV-TR
[27] to overcome short-comings of existing measures of
individuals’ functioning [28].
Classification based on psychotic experiences
At each time point participants were classified into indi-
viduals at UHR for psychosis as opposed to those who
did not fulfil UHR criteria (“non-UHR”). A further dis-
tinction was made concerning the relevance of the func-
tioning criterion for the definition of UHR status:
individuals with psychotic experiences with both an in-
tensity and frequency of at least three on the CAARMS,
but without a 30% drop in functioning or chronic low
functioning (SOFAS score ~ 50 during the past
12 months) were referred to as “psychotic experiences
without functional decline” (as opposed to UHR who ex-
perienced either this described drop in functioning or
chronic low functioning). All combinations of an inten-
sity and frequency of less than three on all sub-scales
were considered as “no significant psychotic experi-
ences”, regardless of functioning. Hence, an additional
three-group comparison was conducted with individuals
at UHR, individuals with psychotic experiences without
functional decline and individuals with no significant
psychotic experiences.
Quick Inventory of Depressive Symptoms (QIDS)
The QIDS [29] is a 16-item, semi-structured interview
to gauge severity of depressive symptoms over the past
7 days. Items are scored 0–3 and total scores range from
0 to 27. A meta-analysis reported concurrent validity,
e.g. with the Hamilton Rating Scale for Depression ran-
ging from 0.72 to 0.79 and a Cronbach’s α ranging from
0.65 to 0.87 [30]. Cronbach’s α in this sample ranging
from 0.61 to 0.78 across time points.
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Overall Anxiety Severity and Impairment Scale (OASIS)
The OASIS [31] is a brief five-item self-report question-
naire of severity and impairment across multiple anxiety
disorders and sub-threshold anxiety. It captures fre-
quency and intensity of anxiety, avoidance behaviour
and interference of anxiety with everyday life and
relationships. Total scores range from 0 to 20. The
OASIS showed convergence with major anxiety mea-
sures (e.g. for social, posttraumatic stress, and general-
ised anxiety), a Cronbach’s α of 0.84 for the five items
[31], and one-month re-test reliability of 0.82 [32].
Kessler psychological distress scale (K-10)
The K-10 [33] is a 10-item self-report questionnaire
assessing psychological distress via questions about de-
pressive and anxiety symptoms in the past 30 days.
Items are rated on a five-point scale with total scores
ranging from 10 to 50. The K-10 is a moderately reliable
instrument (kappa ranging from 0.42 to 0.74) [34] and
demonstrates good concurrent validity with other instru-
ments such as the General Health Questionnaire and
current diagnosis of anxiety and affective disorders [35].
Cronbach’s α in this sample ranged from 0.88 to 0.89
across time points.
Psychosocial functioning
The Global Functioning: Social [36] and Role [37] Scales
are semi-structured interviews and were used to index
current social and role functioning, providing overall scores
from 1 to 10, with 10 indicating superior functioning and 1
extreme dysfunction. Inter-rater reliability ranged from 0.85
to 0.95, and the social functioning scale was significantly
correlated with social contacts (r = 0.70) and role function-
ing with work and school functioning (r = 0.57) [38].
Quality of life
Perceived quality of life was assessed using the World
Health Organisation Quality of Life (WHOQoL) [39]
self-reported item “Thinking about your life in the last
four weeks, how would you rate your quality of life”, on
a five-point scale from 1 (“very poor”) to 5 (“very good”)
retrieved from the 26-item measure WHO-BREF. All
four domains of quality of life of the WHO-BREF corre-
lated significantly with this item, whereby psychological
and environmental domains were more strongly associ-
ated as compared to social and physical domains. This
indicates that the item that we used not only demon-
strated face validity but also represents the WHO-BREF,
which is characterised by good to excellent psychometric
properties, well [40].
Statistical analysis
An independent samples t-test was used to compare
UHR and non-UHR individuals for age. For analysis of
categorical data, such as gender, ethnicity, occupation
and highest education, χ2 tests were used to evaluate
group differences. To increase robustness of findings,
binary linear regression analyses were conducted to
identify whether or not attending any of the three
follow-up assessments was related to high or low scores
in any of the clinical or functioning measures or quality
of life at the respective prior assessment.
As there was incomplete data at all four time points (34
individuals who completed all assessments), mixed linear
modelling was implemented using four time points (base-
line, three, six and 12 months) for both the UHR vs
non-UHR comparison and classification of no significant
psychotic experiences, UHR, and psychotic experiences
without functional decline for the dependent variables
QIDS, OASIS, K-10, social and role functioning, and
WHOQoL score. Group and time (and their interaction)
were specified as fixed effects in the model as we assumed
that individual-specific effects were correlated with both
factors. Bonferroni post-hoc tests were used to compare
QIDS, K-10, OASIS, and WHOQoL scores between UHR,
individuals with psychotic experiences without functional
decline and no significant psychotic experiences within
the mixed linear modelling analyses.
Results
Demographics and UHR vs non-UHR group comparisons
at baseline
At baseline, 56.2% (n = 41) of participants presented with
no significant psychotic experiences, 19.2% (n = 14) were
experiencing psychotic experiences without functional de-
cline, whereas another 19.2% (n = 14) of individuals were
at UHR. Four participants fulfilled CAARMS criteria for a
FEP (5.5%) and were therefore excluded from the remain-
der of the study, leaving a final sample of 69 participants.
Out of the final sample of 69 individuals, the 14 individ-
uals with psychotic experiences without functional decline
(20.3%) and 41 individuals with no significant psychotic
experiences (59.4%) formed the non-UHR group, as
opposed to the UHR group (n = 14; 20.3%).
Transition to FEP according to CAARMS rating was
monitored and recorded for two participants at the
three-month follow-up assessment and an additional
participant at the six-month follow-up assessment for
those individuals who took part in the respective as-
sessments. No further transitions were recorded for the
12-month follow-up assessment (overall transition rate
of 3/69 of whole sample: 4%; overall transition rate of
3/15 individuals identified as UHR at baseline: 27%).
The total sample (n = 69, 48 females, 69.6%) had a
Mage ± SD of 20.8 ± 2.6 years and was predominantly
White-British. At baseline, there were no significant
group differences on demographic variables between
UHR and non-UHR individuals (see Table 1).
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None of the clinical or functioning measures or quality of
life were associated with non-attendance at three, six and
12 months follow, except for lower OASIS scores at
3 month follow-up that predicted non-attendance at
6 month follow-up (6 month follow-up attendance, n = 45,
OASIS M± SD: 7.9 ± 3.9; 6-months follow-up
non-attendance, n = 6, OASIS M± SD: 3.3 ± 3.1; p = 0.036).
Longitudinal UHR vs non-UHR group comparisons
Statistical comparisons revealed that there were no dif-
ferences between those individuals that were included in
the baseline analyses and those who did not take part at
three, six or 12 month follow-up concerning any clinical
baseline measures or classification as UHR and
non-UHR (all p > 0.05). UHR vs non-UHR classification
at three, six, and 12-month follow-up was conducted in
accordance with procedure of baseline classification, yet
with ratings from each respective assessment. Due to the
small number of transitions (n = 3) and the fact that
transition to FEP was determined on the basis of the
CAARMS as a classification tool and not on clinical cri-
teria or eligibility for treatment with early intervention
services, data was handled as “non-UHR” in all three
follow-up cases due to no drop in or chronic low
functioning (and as “psychotic experiences without func-
tional decline” for the three-group comparison in 3.3).
However, additional mixed linear modelling was con-
ducted that excluded the three transitioned cases, to in-
vestigate robustness of findings.
Ten individuals were classified as UHR at 3 month
(16.9%), nine at 6 month (16.3%) and ten at 12-month
follow-up (25.6%). Three individuals (4.3%) were classi-
fied as UHR at all their assessments, 44 (63.8%) were
classified as non-UHR at all their assessments, and 22
(31.9%) changed UHR status at least once during the
follow-up period. Linear mixed effects modelling was
conducted with time (baseline, three, six and 12 months)
and group (UHR vs non-UHR) factors, where group af-
filiation allowed for change across the four time points
(e.g. from non-UHR at baseline to UHR at 3 months or
vice versa). Analyses revealed significant group
differences between UHR and non-UHR across the four
time points for the following: QIDS (F (1, 132.26) = 15.27,
p < 0.001), K-10 (F (1, 114.91) = 12.64, p = 0.001), role
functioning (F (1, 159.87) = 21.52, p < 0.001) and WHO-
QoL (F (1, 160.54) = 7.68, p = 0.006). UHR individuals
demonstrated overall higher QIDS scores, and K-10 scores
and lower role functioning and WHOQoL scores.
Significant time effects were found for the QIDS (F (3,
65.30) = 6.43, p = 0.001), OASIS (F (3, 59.54) = 5.58,
p = 0.002), K-10 (F (3, 54.44) = 5.48, p = 0.002) and
WHOQoL (F (3, 79.72) = 2.87, p = 0.042) indicating a ten-
dency for improvement in symptomatology and quality of
life over time in the group as a whole. No interaction ef-
fects were found. When analyses were repeated without
the three cases who transitioned to psychosis over the
follow-up period, results from linear mixed effects model-
ling remained qualitatively very similar, except that all sig-
nificant time effects disappeared. Measures of central
tendency for QIDS, OASIS, K-10, social and role function-
ing and WHOQoL scores across the four time points
between UHR and non-UHR individuals are illus-
trated in Fig. 1.
Classification into UHR, psychotic experiences without
functional decline and no significant psychotic experiences
from baseline to follow-up
Statistical comparisons revealed that there were no dif-
ferences between those individuals that were included in
the baseline analyses and those who did not take part at
Table 1 Baseline demographic information for the total sample,









Age (M ± SD)
in years
20.8 ± 2.6 20.8 ± 3.1 20.7 ± 2.5 t (67) = 0.12,
p = 0.91
Gender (m/f) 21/48 5/9 16/39 X 2 (1) = 0.23,
p = 0.63
Ethnicity
Whitea 58 12 46
Asianb 3 1 2
Blackc 2 0 2 X 2 (3) = 0.88,
p = 0.83
Mixed-raced 6 1 5
Occupation
University studente 18 1 17
College/A-Levels 20 3 17
Unemployed 11 2 9 X 2 (4) = 7.70,
p = 0.10
Employedf 17 7 10
Homemaker 3 1 2
Highest qualification
Universityg 6 1 5
A-Levelsh 31 4 27 X 2 (3) = 2.91,
p = 0.41
GSCEi 26 8 18
No qualification 6 1 5
UHR ultra-high risk, M mean, SD standard deviation, m male, f female
aWhite-British & White-Other
bAsian-Pakistani, Asian-Bangladeshi & Other Asian
cBlack-African
dMixed-Race White-Black-Caribbean
eUndergraduate and postgraduate university students
fWorking full or part-time
gBachelor or Master degree
hA-Levels, National Vocational Qualification (NVQ) Level 4, or equivalent
iGeneral Certificate of Secondary Education (GCSE, year-10 equivalent) or NVQ
level 1 or 2
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three, six or 12 month follow-up concerning any clinical
baseline measures or classification as UHR, psychotic
experiences without functional decline and no significant
psychotic symptoms (all p > 0.05).
Fourteen (23.7%) individuals were classified as psych-
otic experiences without functional decline at baseline,
13 (22.0%) at 3 month, 6 (10.9%) at 6 month and nine
(23.1%) at 12-month follow-up. Overall, there was a var-
iety of trajectories concerning the three-group classifica-
tion from baseline and across the three follow-up time
points, with the majority of individuals presenting as
UHR or psychotic experiences without functional de-
cline for at least one time point (n = 42, 60.9%). Linear
mixed effects modelling revealed significant group differ-
ences between individuals with no significant psychotic
experiences, UHR and psychotic experiences without
functional decline across the four time points for the fol-
lowing: QIDS (F (2, 125.48) = 11.90, p < 0.001), OASIS (F
(2, 123.99) = 4.69, p = 0.011), K-10 (F (2, 97.22) = 11.14,
p < 0.001), and WHOQoL (F (2, 157.77) = 6.51, p = 0.002).
Time effects were found for QIDS (F (3, 63.63) = 5.82,
p = 0.001), OASIS (F (3, 58.38) = 3.73, p = 0.016), K-10
(F (3, 53.15) = 3.99, p = 0.012) and WHOQoL (F (3, 79.50)
= 3.22, p = 0.027). No interaction effects were found.
When analyses were repeated without the three cases that
transitioned over the follow-up period, results from linear
mixed effects modelling remained similar. Figure 2
illustrates this three-group comparison for QIDS and
OASIS, K-10, and WHOQoL at all four time points.
Bonferroni post hoc tests indicated a difference be-
tween those with no psychotic experiences as compared
to those with psychotic experiences without functional
decline and as compared to UHR individuals (except for
OASIS score between those with no psychotic experi-
ences and UHR individuals and for WHOQoL score be-
tween those with and without psychotic experiences),
but no differences between individuals at UHR as com-
pared to those with psychotic experiences without func-
tional decline (see Table 2).
Discussion
In the present study we examined the role of psychotic
experiences in predicting current and future psychopath-
ology, psychosocial functioning and quality of life in a
sample of young, help-seeking individuals with mental
health problems. Although participants were recruited
from general (not UHR-specific) services, one fifth were
classified as UHR for psychosis and an additional one
fifth had significant psychotic experiences without func-
tional decline at entry to the study, comparable to the
rate in similar studies (e.g. [41]). Mostly consistent with
our hypotheses, UHR individuals reported higher levels
of depressive symptoms and psychological distress, and
lower levels of role functioning and quality of life
Fig. 1 Clinical measures, functioning and quality of life for UHR and non-UHR over time. QIDS = Quick Inventory of Depressive Symptoms, K-10 =
Kessler Psychological Distress Scale, OASIS=Overall Anxiety Severity and Impairment Scale, Social = social functioning, Role = role functioning,
WHOQoL =Quality of life, UHR = ultra-high risk; central tendency displayed as mean +/− standard deviation for depressive symptoms, psychological
distress and anxiety symptoms and as median +/− interquartile range for social and role functioning and quality of life scores
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compared to non-UHR individuals. As opposed to our
hypotheses, no differences were reported for anxiety
symptoms or social functioning. When we explored the
predictive value of the functioning criterion for defin-
ition of UHR status, as predicted, there were no signifi-
cant differences in all measures between individuals at
UHR and those with psychotic experiences without
functional decline.
There were no group differences between UHR and
non-UHR individuals on anxiety symptoms, and social
functioning, although the UHR group showed signifi-
cantly higher depressive symptoms and substantially
lower levels of role functioning than non-UHR individ-
uals. This may likely be explained by the nature of the
UHR status and the drop in functioning or chronic low
functioning being driven by low levels of role function-
ing. It is possible that low role functioning is particularly
characteristic for this sample comprising of UHR indi-
viduals not specifically help-seeking for psychotic experi-
ences but for general mental health problems. Most
UHR studies report psychosocial functioning combined
(e.g. [10, 21, 22]), however, studies that examined social
and role functioning separately using the same measure,
found similar levels of social functioning and higher
levels of role functioning as compared to the current
study (e.g. [38]). Role functioning may therefore be a
particularly important target for early intervention, for
example, in terms of vocational and educational inter-
ventions in addition to symptom-oriented psychother-
apy. Vocational rehabilitation was found to be effective
in chronic schizophrenia [42], and has recently been
introduced to individuals with a FEP in a randomised
controlled trial [43], yet there may be a need for such in-
terventions even earlier in the course of illness.
The finding of higher depressive symptoms and psy-
chological distress, and lower role functioning and qual-
ity of life in UHR individuals as compared to non-UHR
individuals is in accordance with Wigman et al. [44] who
found that clients with non-psychotic psychiatric disor-
ders but additional psychotic experiences showed lower
global functioning than those without psychotic experi-
ences. Psychotic experiences have also been shown to
predict depressive symptoms in the future [45], yet it
has to be acknowledged that there is also contrary evi-
dence indicating a cross-sectional association only [13].
These findings are also consistent with the idea that
psychotic experiences are associated with more severe
mental health problems [12, 46].
Fig. 2 Three-group comparison of clinical measures and quality of life over time. QIDS = Quick Inventory of Depressive Symptoms, K-10 = Kessler
Psychological Distress Scale, OASIS=Overall Anxiety Severity and Impairment Scale, UHR = ultra-high risk for psychosis, psy. exp. = psychotic
experiences without functional decline, no psy. exp. = no significant psychotic experiences; central tendency displayed as mean +/− standard
deviation for depressive symptoms, psychological distress and anxiety symptoms and as median +/− interquartile range for quality of life scores
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UHR status was assessed at each follow up assessment
and not only at baseline. This is especially important con-
sidering the dynamics of clinical presentation. Indeed, al-
most one third of individuals changed from UHR to
non-UHR (or vice versa) at least once over the follow-up
period of only 12 months. This indicates that UHR is not
a static concept and clinicians should be aware of the po-
tential for rapid changes in symptomatology.
A considerable amount of the UHR literature has fo-
cused on transition to psychosis as the primary outcome.
However, it is not only the prediction of transition to
psychosis that is key to ensuring young people with men-
tal health problems receive the care they need – focusing
on other psychopathology is equally important consider-
ing outcomes of those individuals who do not transition
to psychosis. Lin et al. [10] followed non-transitioned
UHR individuals and found that more than two thirds ex-
perienced non-psychotic disorders over the follow-up
period of up to 14 years, with 90% presenting with
non-psychotic disorders at baseline. This study supports a
shift of emphasis from categorical outcomes (e.g. transi-
tion to psychosis or assignment of clinical diagnosis) to a
more holistic approach of mental health outcomes. In the
current sample only 4% transitioned to psychosis, but
many experienced ongoing significant psychopathology.
This current study illustrated the distribution of clin-
ical symptoms and quality of life of individuals at UHR
and those with psychotic experiences without functional
decline and participants with no significant psychotic ex-
periences. Post-hoc tests revealed no significant differ-
ences between individuals at UHR and those with
psychotic experiences without functional decline. Thus
we found no evidence for an exacerbation in clinical
symptomatology if functional decline or chronic low
functioning was present. Whereas the inclusion of func-
tional decline for UHR status definition serves its pur-
pose to increase specificity of prediction of psychosis
[21], it may not be a robust marker for prediction of
clinical deterioration or a decrease in quality of life.
However, the current results should be interpreted with
caution considering the small group sizes.
Lastly, individuals who took part in this study were re-
cruited from both a primary and secondary mental
health service in the UK. It is plausible that individuals
presenting to secondary mental health services are more
impaired concerning their mental health and psycho-
social functioning as those presenting to primary care
services, considering that the UK operates on general
practioner referral who are likely to have more conserva-
tive thresholds of what constitutes a psychiatric case as
opposed to countries that operate on self-referral for
mental health issues [47]. However, actual access to sec-
ondary care may be more driven by cost of and capacity
for service provision than need for clinical care or illness
severity: examination of transition protocols from child
to adolescent mental health services revealed that only
one quarter of cases that were deemed suitable for tran-
sition, actually ‘graduated’ to an adult mental health ser-
vice, leaving a service gap especially for 16 and 17 year
olds where mental health services are disproportionately
expensive [48].
There were several limitations to the current study.
The study was characterised by reasonably high attrition
rates and the cohort was followed-up over only
12 months, although these first 12 months appear to be
the most relevant time period, including the highest
number of actual transitions to a FEP [49]. Although the
sample was quite small (in particular the numbers of in-
dividuals at UHR and those with psychotic experiences
without functional decline), the participants provided
detailed and comprehensive psychopathological informa-
tion. The sample comprised a very heterogeneous clin-
ical presentation (including heterogeneous treatment
and care setting for help-seeking which we were not able
to control for in our analyses) with participants differing
widely from none to severe symptom presentation across
diagnostic categories. However, the presented findings
are not fixed to diagnostic categories during the early
stages of mental health, constituting a different approach
to mental health that aims to circumvent issues around
comorbidity [50] and the question of the existence of
natural boundaries between mental disorders [51].






No psy. exp. vs psy. exp. 0.011*
No psy. exp. vs UHR < 0.001***
Psy. exp. vs UHR 0.639
K-10
No psy. exp. vs psy. exp. 0.029*
No psy. exp. vs UHR < 0.001***
Psy. exp. vs UHR 0.664
OASIS
No psy. exp. vs psy. exp. 0.015*
No psy. exp. vs UHR 0.153
Psy. exp. vs UHR 1.00
WHOQoL
No psy. exp. vs psy. Exp. 0.251
No psy. exp. vs UHR 0.002**
Psy. exp. vs UHR 0.427
QIDS Quick Inventory of Depressive Symptoms, OASIS Overall Anxiety Severity
and Impairment Scale, K-10 Kessler Psychological Distress Scale, no psy. exp no
significant psychotic experiences, psy. exp psychotic experiences without functional
decline, UHR ultra-high risk for psychosis
*p < 0.05, **p < 0.01, ***p < 0.001
Heinze et al. BMC Psychiatry  (2018) 18:214 Page 8 of 10
Conclusions
The current study explored the role of psychotic experi-
ences and being at UHR for psychosis in youth who were
seeking help for common, non-psychotic mental health
problems. Individuals at UHR for psychosis demonstrated
significantly higher levels of depressive symptoms and psy-
chological distress, and lower role functioning and quality
of life, as compared to non-UHR individuals. Therefore, in
addition to symptom-orientated psychotherapy, it may be
important to also focus on individuals’ compromised role
functioning, and consider using vocational and educational
rehabilitation in these early stages of mental health prob-
lems. Lastly, functional decline and chronic low functioning
did not exacerbate clinical symptomatology and may there-
fore not be a robust marker for prediction of clinical deteri-
oration or a decrease in quality of life.
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